20 Democrat, 1 GOP State AGs Frame OTC Birth Control Within Protecting Reproductive Rights

Citing national uncertainty regarding reproductive health care – “ a time when reproductive rights have been curtailed across the country – state AGs urge FDA to approve OTC birth control proposal from HRA Pharma.

• Source: Shutterstock

The US Food and Drug Administration must preserve women’s access to reproductive health care and approve OTC access to birth control pills which meet safety and efficacy standards, attorneys general from 21 states urge agency Commissioner Robert Califf.

A letter sent on 3 November by 20 Democrat and one Republican state attorneys general in response to FDA’s...

Welcome to HBW Insight

Create an account to read this article

More from Rx-to-OTC Switch

Opella Switches Cialis In Norway

 
• By 

Norway becomes the third European country to approve OTC sales of tadalafil. Cialis reseptfri will “soon be on shelves,” Opella says, with the launched being planned in partnership with Stada Arzneimittel.

German Switch Committee Supports OTC Melatonin And Acyclovir, Rejects Rupatadine

 
• By 

Germany’s Expert Committee for Prescription supports the Rx-to-OTC switches of melatonin and buccal acyclovir but rejects rupatadine.

Navamedic To Market OTC Naloxone In Norway Following Switch

 
• By 

Navamedic adds Ventizolve to its portfolio shortly after Norway switched the opioid overdose reversal drug from Rx to OTC.

Viatris Switches Innovative Dual Action Nasal Spray In The UK

 
• By 

Now available without a prescription, Dymista Control is the first OTC combination treatment for consumers who are struggling to control their seasonal allergic rhinitis with a corticosteroid or antihistamine nasal spray, according to the firm.

More from Health

German Pain And Cough Launches From Haleon, Bayer And Angelini

 
• By 

Haleon adds herbal pain relief to Voltaren topicals line, Bayer launches herbal expectorant in time for autumn and Angelini creates a throat spray that meets German Society for General Practice and Family Medicine guidelines.

Zantac Litigation Attorney Suggests ‘Slowing Down’ US Drug Approvals ‘To Protect Consumers’

 

Brent Wisner suggests FDA “should be focusing on slowing down and making sure they get it right. Because at the end of the day, getting it right is more important than making sure drug companies can make more money. That shouldn't be the priority.”

Stada Under New Ownership As CapVest Takes Control

 
• By 

Stada is set for new ownership after CapVest agreed to buy a controlling stake from Bain Capital and Cinven. CapVest is pledging to “deploy significant new capital” to advance Stada’s interests, with the German giant’s CEO hinting at “ambitious plans” for the future.